2 of 7
Grand prize: BiologicsMD
Grand prize: BiologicsMD
From left: Michael Thomas, CMO; Robyn Goforth, Chief Scientific Officer; Misty Stevens, COO; Paul Mlaker Jr., CEO
School: University of Arkansas
Business concept: Developing a new prescription drug to combat osteoporosis -- a $9 billion global market.
Judge's comment: "Osteoporosis is clearly a serious problem, and their solution looks to be technically superior, with clear advantages for the patient."

If BiologicsMD's drug builds bones as sturdy as its management team, osteoporosis sufferers will be grateful. Misty Stevens, COO, says she and Robyn Goforth, chief scientific officer, searched hard to find the best fellow students to round out their group, which includes a West Point graduate as president and a CMO who's a national account manager at Colgate-Palmolive by day.

Last fall Goforth, a Ph.D. chemist who's earning a graduate certificate in entrepreneurship, came across information about an invention the University of Arkansas sought to commercialize: a drug that would bind to the bones of osteoporosis sufferers, stimulating the growth of new, high-quality bone. "I said to myself, `Holy crap!' " says Goforth.

After she shared it with Stevens, a biology Ph.D. earning her MBA, they visited one of the inventors. Their goal: to raise $5.3 million for Phase I trials, then sell or sublicense it to Big Pharma. "This is a complex product, and it takes a complex team," says Stevens.

NEXT: 2nd place: Rebellion Photonics

Last updated June 11 2010: 1:32 PM ET
More Galleries
8 CEOs who took a pay cut in 2013 Median CEO pay inched up 9% in 2013 to $13.9 million. But not everyone got a bump last year. Here are eight CEOs who missed out. More
10 best convertibles now that spring has sprung It's finally time to put the top down. Here are our 10 favorite rides for the warmer months to come. More
10 best founding teams The most effective co-founders pair vision with fortitude to launch a business. Here are some of the best examples through the years. More
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.